Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
84.25(c) 82.89(c) 84.31(c) 84.34(c) 83.92(c) Last
6 933 177 9 776 877 8 081 607 4 238 703 7 671 659 Volume
-0.07% -1.61% +1.71% +0.04% -0.50% Change
More quotes
Financials (USD)
Sales 2020 45 372 M - -
Net income 2020 8 566 M - -
Net Debt 2020 74 016 M - -
P/E ratio 2020 16,5x
Yield 2020 5,85%
Sales 2021 53 258 M - -
Net income 2021 16 346 M - -
Net Debt 2021 63 003 M - -
P/E ratio 2021 9,45x
Yield 2021 6,09%
Capitalization 149 B 149 B -
EV / Sales 2020 4,91x
EV / Sales 2021 3,98x
Nbr of Employees 47 000
Free-Float 98,5%
More Financials
Company
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn‚'Ts disease, thyroid disease, Parkinson‚'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Sales are distributed geographically as follows: the United States (71.9%), Japan (3.7%), Germany... 
Sector
Pharmaceuticals
Calendar
10/30Earnings Release
More about the company
Notations Surperformance© of AbbVie Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ABBVIE INC.
10/19ABBVIE : Seeks U.S., European OK of Rinvoq in Eczema
DJ
10/19ABBVIE : VENCLEXTA Receives FDA Full Approval for Acute Myeloid Leukemia
AQ
10/19ABBVIE : Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upada..
PR
10/19ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/19ABBVIE : Announces Commencement of Registered Exchange Offers
PR
10/16NEWS HIGHLIGHTS : Top Company News of the Day
DJ
10/16NEWS HIGHLIGHTS : Top Company News of the Day
DJ
10/16NIH to Study Three Drugs in Treatment of Covid-19 Patients
DJ
10/14ABBVIE INC. : Ex-dividend day for
FA
10/13NIH starts clinical trial testing antibody treatments in COVID-19 patients
RE
10/13J&J raises profit forecast as trial halt weighs
RE
10/12ABBVIE : Allergan Aesthetics to Present Data from 4 Abstracts at the 2020 Americ..
AQ
10/08ABBVIE : Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera De..
AQ
10/07ABBVIE : to Host Third-Quarter 2020 Earnings Conference Call
AQ
10/07ABBVIE : Allergan to Buy Luminera Dermal-Filler Business
DJ
More news
News in other languages on ABBVIE INC.
10/18ROCHE : FDA-Zulassung für Venclexta-Kombinationen bei myeloischer Leukämie
10/17ROCHE : FDA-Zulassung für Venclexta-Kombinationen bei myeloischer Leukämie
09/04Les valeurs à suivre aujourd'hui à Wall Street Vendredi 4 septembre 2020
09/04ABBVIE : partenariat avec le chinois I-MAB
09/04WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
More news
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Average target price 109,25 $
Last Close Price 84,34 $
Spread / Highest target 50,6%
Spread / Average Target 29,5%
Spread / Lowest Target 13,8%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC.-4.74%148 846
JOHNSON & JOHNSON-0.43%382 350
ROCHE HOLDING AG-5.29%280 884
PFIZER INC.-2.55%212 162
MERCK & CO., INC.-12.23%201 909
NOVARTIS AG-16.78%185 999